Global Atopic Dermatitis Drugs Market Analysis, Trends, Market Size & Forecasts to 2024, With an Expected CAGR of 3.5% - ResearchAndMarkets.com

DUBLIN--()--The "Atopic Dermatitis Drugs Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering.

The report predicts the global atopic dermatitis drugs market to grow with a CAGR of 3.5% over the forecast period of 2018-2024.

A disease without a known cause that is caused by both genetic as well as environmental factors is considered as idiopathic or Atopic dermatitis (AD). A skin disorder in which the skin becomes dry, itchy and inflamed, this type of disorder is known as Atopic dermatitis (AD). Scratching of the skin leads to redness, scaling, cracking, weeping, swelling, and crusting. This condition is common in infants and children, even adult population is also affected by this disorder. People living in dry climate are more likely to get affected. Generally, people with AD develop asthma and hay fever.

The growing occurrence of food allergies intensifying atopic dermatitis is likely to drive the growth of this market. Moreover, the growing risk of intense atopic dermatitis in infancy is related to food sensitization, which is commonly related with food allergy. Food items such as cow's milk, chicken eggs, peanuts, wheat, soy, nuts, and fish cause such allergies. The monoclonal antibody named dupilumab, which is developed by Sanofi and Regeneron Pharmaceuticals, Inc., for treating atopic diseases is expected to drive the growth of atopic dermatitis treatment market. Side effects related with drugs used in the treatment of AD are likely to hamper the growth of the market.

Companies Mentioned

  • Mylan
  • LEO Pharma
  • Bayer HealthCare
  • Encore Dermatology
  • Novartis AG
  • Valent Pharmaceutical Inc.
  • Astellas Pharma Inc.
  • Meda AB
  • Valeant

Key Topics Covered:

1. Preface

2. Executive Summary

3. Global Atopic Dermatitis Drugs Market Overview

4. Global Atopic Dermatitis Drugs Market by Route of Administration

5. Global Atopic Dermatitis Drugs Market by Region 2018-2024

6. Company Covered

For more information about this report visit https://www.researchandmarkets.com/research/f3zlnt/global_atopic?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Immune Disorders Drugs, Dermatological Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Immune Disorders Drugs, Dermatological Drugs